

Christina Clarke
All Publications Gomez SL, Lichtensztajn D, Kurian AW, Telli ML, Chang ET, Keegan THM, Glaser SL, Clarke CA. Increasing mastectomy rates for early-stage breast cancer? population-based trends in California. Journal of Clinical Oncology. (in press). Marshall SF, Clarke CA, Deapen D, Delellis Henderson K, Largent J, Neuhausen SL, Reynolds P, Ursin G, Horn-Ross PL, Stram DO, Templeman C, Bernstein. Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. Breast Cancer Res. 2010;12(1):r4. Prescott J, Lu Y, Chang ET, Sullivan-Halley J, Henderson KD, Clarke CA, Ma H, Templeman C, Deapen D, Bernstein L. Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers study. PLoS One. 2009;4(12):e8135. Chang ET, Shema SJ, Wakelee HA, Clarke CA, Gomez SL. Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California. Cancer Epidemiology Biomarkers & Prev 2009; 18(8):2248-2255. Cheng I, John EM, Witte JS, Cockburn MG, Clarke CA. Socioeconomic status and prostate cancer incidence and mortality among the diverse population of California. Cancer Causes and Control 2009 [e-pub ahead of print]. Katz KA, Clarke CA, Bernstein KT, Katz MH, Klausner JD. Is there a proven link between anal cancer screening and reduced morbidity or mortality? (letter) Author reply 284-285. Ann Intern Med. 2009;150(4):283-284. Keegan TH, Clarke CA, Chang ET, Shema SJ, Glaser SL. Disparities in survival after Hodgkin lymphoma: a population-based study. Cancer Causes and Control 2009 [epub ahead of print]. Keegan THM, McClure LA, Foran JM, Clarke CA. Improvements in survival after follicular lymphoma by race/ethnicity and socioeconomic status: a population-based study. J Clin Oncol. 2009;27(18):3044-3051. Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA. Second primary breast cancer occurrence according to hormone receptor status. JNCI. 2009;101(15):1058-1065. Lu Y, Sullivan-Halley J, Cozen W, Chang ET, Henderson K, Ma H, Deapen D, Clarke CA, Reynolds P, Neuhausen SL, Anton-Culver H, Ursin G, West D, Bernstein L. Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study. Br J Cancer. 2009;100(3):524-6. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674. Kurian AW, Clarke CA, Carlson RW. The decline in breast cancer incidence: real or imaginary? Curr Oncol Rep. 2009;11(1):21-8. Templeman C, Marshall SF, Clarke CA, Delellis Henderson K, Largent J, Neuhausen S, Reynolds P, Ursin G, Bernstein L. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril. 2009;92(4):1436-1446. West DW, Clarke CA. Rapidly increasing trends of melanoma in nonwhite populations: new data from New Zealand. Cancer Epidemiol Biomarkers Prev. 2009;18:1674-75. Cockburn M, Swetter S, Keegan THM, Peng D, Deapen D, Clarke CA. Melanoma under-reporting: why does it happen, how big is the problem, and how do we fix it? J Am Acad Dermatol. 2008;59(6):1081-1085. Carreon DJ, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control 2008;19(10):1171-81. Pollitt RA, Clarke CA, Shema SJ, Swetter SM. California medicaid enrollment and melanoma stage at diagnosis a population-based study. Am J Prev Med 2008 Jul;35(1):7-13. Epub 2008 May 14. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25(5):472-8. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL. Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort. Am J Epidemiol. 2007;165(1):802-13. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadie M, Spinelli JJ, Costantini AS, Rudiger T, Scarpa A, Zheng T, Weisenburger DD. Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110(2):695-708. Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007;109(10):2100-8. Chang ET, Clarke CA, Glaser SL. Making sense of seasonal fluctuations in lymphoma diagnosis. Leuk Lymphoma. 2007;48(2):223-4. Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, Bernstein L, Stram DO, Anton-Culver H, Deapen D, Mohrenweiser H, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control. 2007;18(1):91-103. Mai PL, Sullivan-Halley J, Ursin G, Stram DO, Deapen D, Villaluna D, Horn-Ross PL, Clarke CA, Reynolds P, Ross RK, West DW, Anton-Culver H, Ziogas A, Bernstein L. Physical activity and colon cancer risk among women in the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2007;16(3):517-25. Robbins AS, Clarke CA. Regional Changes in Hormone Therapy Use and Breast Cancer Incidence in California From 2001 to 2004. J Clin Oncol. 2007;25(23):3437-9. Robbins AS, Clarke CA. A decline in breast-cancer incidence. N Engl J Med. 2007;357(5):511-2; author reply 513. Clarke CA, Glaser SL. Declines in breast cancer after the WHI: Apparent impact of hormone therapy. Cancer Causes Control. 2007;8:847-52. Glaser SL, Chang ET, Horning SJ, Clarke CA. Understanding the validity of self-reported positive family history of lymphoma in extended families to facilitate genetic epidemiology and clinical practice. Leuk Lymphoma. 2007;48(6):1110-1118. Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL, Reynolds P, Stram DO, Clarke CA, Anton-Culver H, Ziogas A, Peel D, West DW, Wright W, Bernstein L. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med. 2007;167(4):408-15. Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev. 2006;15(4):630-8. Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer. 2006;6(1):70. Keegan TH, Glaser SL, Clarke CA, Dorfman RF, Mann RB, DiGiuseppe JA, Chang ET, Ambinder RF. Body size, physical activity, and risk of Hodgkin's lymphoma in women. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1095-101. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ . Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24(33);e49-50. Keegan TH, Gomez SL, Clarke CA, Chan JK, Glaser SL. Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California. Int J Cancer 2006; 129(6):1324-9. O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006;96(12):2179-85. Chan JK, Gomez SL, O'Malley CD, Perkins CI, Clarke CA. Validity of Cancer Registry Medicaid Status Against Enrollment Files: Implications for Population-Based Studies of Cancer Outcomes. Med Care. 2006;44(10):952-955. Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study. J Clin Oncol. 2005;23(30):7604-13. Glaser SL, Clarke CA, Gomez SL, O'Malley CD, Purdie DM, West DW. Cancer surveillance research: A vital subdiscipline of cancer epidemiology. Cancer Causes Control. 2005;16(9):1009-19. Phipps AI, Clarke CA, Ereman RR. Impact of intercensal population projections and error of closure on breast cancer surveillance: Examples from 10 California counties. Breast Cancer Res. 2005;7(5):R655-60. Clarke CA, Glaser SL, Keegan TH, Stroup A. Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1441-7. Glaser SL, Keegan TH, Clarke CA, Trinh M, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women. Int J Cancer. 2005;115(4):599-605. Glaser SL, Clarke CA, Keegan TH, Gomez SL, Nugent RA, Topol B, Stearns CB, Stewart SL. Attenuation of social class and reproductive risk factor associations for Hodgkin lymphoma due to selection bias in controls. Cancer Causes Control. 2004;15(7):731-9. Clarke CA, Glaser SL. Population-based surveillance of HIV-associated cancers: utility of cancer registry data. J Acquir Immune Defic Syndr. 2004;36(5):1083-91. Glaser SL, Keegan TH, Clarke CA, Darrow LA, Gomez SL, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Smoking and Hodgkin lymphoma risk in women United States. Cancer Causes Control. 2004;15(4):387-97. Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: Reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev. 2004;13(1):138-43. Benz CC, Clarke CA, Moore DH. Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(12):1523-7. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Reproductive factors in Hodgkin's disease in women. Am J Epidemiol. 2003;158(6):553-63. Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer. 2003;98(2):300-9. Wrensch MR, Chew T, Farren G, Barlow J, Belli F, Clarke C, Erdmann C, Lee M, Peskin-Mentzer R, Quesenberry C, Souders-Mason V, Moghadassi M, Spence L, Suzuki M, Gould M. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res. 2003;98(2):300-309. Glaser SL, Clarke CA, Darrow LA. Hodgkin's disease etiology and novel viruses: clues from groups exposed to blood products. Int J Cancer. 2003;104(6):796-7. Gomez SL, Clarke CA, Glaser SL. Cancer survival in US racial/ethnic groups: heterogeneity among Asian ethnic subgroups. Arch Intern Med. 2003;163(5):631-2; author reply 632. Clarke CA, West DW, Edwards BK, Figgs LW, Kerner J, Schwartz AG. Existing data on breast cancer in African-American women: what we know and what we need to know. Cancer. 2003;97(1)(Suppl):211-21. Clarke CA, Glaser SL, West DW, Ereman RR, Erdmann CA, Barlow JM, Wrensch MR. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999. Breast Cancer Res. 2002;4(6):R13. Lin SS, Clarke CA, O'Malley CD, Le GM. Studying cancer incidence and outcomes in immigrants: methodological concerns. Am J Public Health. 2002;92(11):1757-9. Le GM, Gomez SL, Clarke CA, Glaser SL, West DW. Cancer incidence patterns among Vietnamese in the United States and Ha Noi, Vietnam. Int J Cancer. 2002;102(4):412-7. Lin SS, O'Malley CD, Clarke CA, Le GM. Birthplace and survival among Asian women diagnosed with breast cancer in cancer registry data: The impact of selection bias. Int J Epidemiol. 2002;31(2):511-3; author reply 513. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94(7):2015-23. Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O'Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer. 2002;94(4):1175-82. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer. 2002;98(1):110-7. Prehn A, Clarke C, Topol B, Glaser S, West D. Increase in breast cancer incidence in middle-aged women during the 1990s. Ann Epidemiol. 2002;12(7):476-81. Glaser SL, Clarke CA, Stearns CB, Dorfman RF. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma. 2001;42(5):997-1004. Clarke CA, Glaser SL, Prehn AW. Age-specific survival after Hodgkin's disease in a population-based cohort (United States). Cancer Causes Control. 2001;12(9):803-12. Clarke CA. Changing incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among young men in San Francisco. AIDS. 2001;15(14):1913-1915. Clarke CA, Glaser SL. Epidemiologic trends in HIV-associated lymphomas. Curr Opin Oncol 2001; 13(5):354-9. Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer. 2001;92(2):218-24. Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer. 2001;91(8):1579-87. Clarke CA, Glaser SL. Acute myeloid leukemia. N Engl J Med 2000; 342(5):358-9.
|
©2009 Northern California Cancer Center
2201 Walnut Avenue, Suite 300, Fremont, CA 94538. (510) 608-5000












